Cargando…

The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches

Objectives: FDA has approved Onabotulinum toxin type A (BoNTA) for prophylactic treatment of chronic migraines. Recent studies have explored its potential new indications, like treating post-traumatic headaches. Patients and Methods: This is a retrospective chart review of 717 patients, who had fail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Cassie, Lucchese, Scott, Zhang, Fang, Govindarajan, Raghav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763695/ https://www.ncbi.nlm.nih.gov/pubmed/31616362 http://dx.doi.org/10.3389/fneur.2019.01009

Ejemplares similares

Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review
por: Lucchese, Scott, et al.
Publicado: (2023)

Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients
por: Ali, Sameer S, et al.
Publicado: (2019)

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations
por: Barbanti, Piero, et al.
Publicado: (2017)

Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
por: Viticchi, Giovanna, et al.
Publicado: (2022)

Laugh Headache, Not a Joke! A Case Report
por: Daripa, Bob, et al.
Publicado: (2022)

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
por: Corbelli, Ilenia, et al.
Publicado: (2022)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Long‐Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion – An Observational Study
por: Aschehoug, Irina, et al.
Publicado: (2018)

Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions
por: Singh, Harsh, et al.
Publicado: (2020)

Risks of suicide in migraine, non-migraine headache, back, and neck pain: a systematic review and meta-analysis
por: Giakas, Alec, et al.
Publicado: (2023)

Caffeine and Primary (Migraine) Headaches—Friend or Foe?
por: Alstadhaug, Karl B., et al.
Publicado: (2019)

Dysbiosis and Migraine Headaches in Adults With Celiac Disease
por: Qasim, Hodan, et al.
Publicado: (2022)

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
por: García-Azorín, David, et al.
Publicado: (2022)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Development and Validation of a Japanese-Language Questionnaire to Screen for Tension-Type Headaches and Migraines
por: Tanobe, Kaho, et al.
Publicado: (2023)

Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker
por: Bumb, Anja, et al.
Publicado: (2013)

Giving Researchers a Headache – Sex and Gender Differences in Migraine
por: Al-Hassany, Linda, et al.
Publicado: (2020)

Non-surgical Brachioplexy Using Polydioxanone Threads and Onabotulinum Toxin Type A in an Indian Female Patient: A Case Report
por: Arora, Reema Tebak, et al.
Publicado: (2022)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Association of Suicide Risk With Headache Frequency Among Migraine Patients With and Without Aura
por: Lin, Yu-Kai, et al.
Publicado: (2019)

Pain Catastrophizing in Childhood Migraine: An Observational Study in a Tertiary Headache Center
por: Sciruicchio, Vittorio, et al.
Publicado: (2019)

Theory of Mind in migraine and medication-overuse headache: A cross-sectional study
por: Romozzi, Marina, et al.
Publicado: (2022)

Prevalence of Migraine Headache in Saudi Arabia: A Systematic Review and Meta-Analysis
por: Albalawi, Mohammed Faisal, et al.
Publicado: (2023)

A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
por: Kim, Young-gun, et al.
Publicado: (2020)

EHMTI-0278. Onabotulinum toxin a for hemicrania continua: a case series of 8 patients
por: Miller, S, et al.
Publicado: (2014)

Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study
por: Hastings-Ison, T., et al.
Publicado: (2018)

New Injection Points of Onabotulinum Toxin A for Spastic Paralysis of the Fingers: Eight Cases of Report
por: Yamada, Shoko Merrit, et al.
Publicado: (2020)

Nummular headache: a case report of remission following ketogenic diet and botulinum toxin type A injections
por: Tereshko, Yan, et al.
Publicado: (2023)

Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects
por: Teggi, Roberto, et al.
Publicado: (2018)

Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events
por: Bottiroli, Sara, et al.
Publicado: (2019)

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine
por: Herd, Clare P, et al.
Publicado: (2019)

O048. Chronic migraine, cluster headache or both? The suggestion of botulinum toxin
por: Ripa, Patrizia, et al.
Publicado: (2015)

Corrigendum: Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects
por: Teggi, Roberto, et al.
Publicado: (2020)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

A preliminary trial of botulinum toxin type A in patients with vestibular migraine: A longitudinal fMRI study
por: Oh, Sun-Young, et al.
Publicado: (2022)

Extracranial Trigger Site Surgery for Migraine: A Systematic Review With Meta-Analysis on Elimination of Headache Symptoms
por: Vincent, Arnaud J. P. E., et al.
Publicado: (2019)

Cluster and network analysis of non-headache symptoms in migraine patients reveals distinct subgroups based on onset age and vestibular-cochlear symptom interconnection
por: Li, Hui, et al.
Publicado: (2023)

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine
por: Sarchielli, Paola, et al.
Publicado: (2017)

Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diary
por: Lipton, Richard B., et al.
Publicado: (2023)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
por: Kępczyńska, Katarzyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kao5st1oqk0sdduvi810ckra8i